|
![]() |
|||
|
||||
OverviewThis publication covers topics related to the biochemistry and clinical significance of the proteins displaying thrombin-inhibiting activity. Only in the past twenty-five years has the biological significance of proteins inhibiting blood coagulation been recognized. These inhibitors play a key role in the regulation of blood coagulation by controlling the activated serine proteinases. Certain proteins, the antithrombins, exert their effect upon thrombin leading to a reduction in the rate of fibrin formation. Important work has been done with thrombosis; chronic liver disease; disseminated intravascular coagulation; thromboembolic episodes during pregnancy, delivery; and oral contraceptive therapy. Substitution of purified, concentrated antithrombin III fractions has proven to be an effective and safe therapy for patients with antithrombin-III deficiencies. This important addition to scientific literature is of value to those of hematology, thrombosis research, transfusion technology and biochemistry. Full Product DetailsAuthor: Geza Sas (Postgrad. Medical Inst., Budapest, Hungary)Publisher: Taylor & Francis Inc Imprint: CRC Press Inc Weight: 0.566kg ISBN: 9780849347771ISBN 10: 0849347777 Pages: 192 Publication Date: 30 November 1989 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Out of Print Availability: Out of stock ![]() Table of ContentsReviewsAuthor InformationSas\, Geza Tab Content 6Author Website:Countries AvailableAll regions |